Drugs News and Research

RSS

Researchers identify an enzyme associated with kidney fibrosis in both mice and humans

Researchers at Nagoya University in Japan have identified two enzymes that are involved in macrophage polarization, one of the key factors affecting fibrosis.

22 Mar 2023

Common genetic signature may increase a person's risk of developing substance use disorders

A new study suggests that a common genetic signature may increase a person's risk of developing substance use disorders, regardless of whether the addiction is to alcohol, tobacco, cannabis or opioids.

22 Mar 2023

Researchers discover how a single mechanosensitive protein induces fibrosis

Researchers from Kyushu University have found how a single mechanosensitive protein induces the process that thickens and scars tissue, known as fibrosis. The protein, called VGLL3, was shown to contribute to fibrosis in multiple organs.

22 Mar 2023

Animal studies show potential of new drug to curb painful hyperinflammation from osteoarthritis

A team of researchers at the Keck School of Medicine of USC have found a drug with the potential for curbing painful hyperinflammation from osteoarthritis, according to results of an animal study.

22 Mar 2023

Researchers discover how a mutation in the desmosomal gene leads to arrhythmogenic cardiomyopathy

Mutations in genes that form the desmosome are the most common cause of the cardiac disease arrhythmogenic cardiomyopathy (ACM), which affects one in 2000 to 5000 people worldwide.

22 Mar 2023

Study finds shared genetic risk variants across different substance use disorders

By combing through genomic data of over 1 million people, scientists have identified genes commonly inherited across addiction disorders, regardless of the substance being used.

22 Mar 2023

Naturally-occurring compound found in trees effective in fighting superbugs

Researchers at the University of Portsmouth have discovered that a naturally-occurring compound found in trees is effective in combating superbugs.

22 Mar 2023

Study reveals why COVID-19 subvariants spread rapidly among previously infected people

The COVID-19 pandemic has killed nearly 7 million people worldwide (1.1 million in the United States) and severely harmed many millions more, though vaccines and antiviral treatments measurably reduced the potential loss of life and health.

22 Mar 2023

Public’s view of obesity has changed since the pandemic, survey shows

Nearly a third of Americans (29%) say COVID-19 made them more worried than ever about having obesity prompting about 28 million people to consider weight-loss methods they hadn't thought about before the pandemic began, including nearly 6.4 million thought about turning to either weight-loss surgery or taking prescription anti-obesity drugs for the first time, according to a new survey whose findings were published online in the peer-reviewed journal, Surgery for Obesity and Related Diseases.

22 Mar 2023

Disruption of the FcRn–IgG interaction may make AAV-based gene therapies effective

The use of a monoclonal antibody that reduced circulating IgG levels, led to a decrease in preexisting neutralizing antibodies (NAbs) to adeno-associated virus (AAV).

22 Mar 2023

New study investigates effect of short-term PM2.5 exposure on blood lipids

A recent Scientific Reports study sought to address a gap in research and determined the association between short-term PM2.5 exposure and blood lipids.

22 Mar 2023

End of covid emergency will usher in changes across the US health system

The Biden administration's decision to end the covid-19 public health emergency in May will institute sweeping changes across the health care system that go far beyond many people having to pay more for covid tests.

22 Mar 2023

Gyros Protein Technologies introduces new PurePep EasyClean services to accelerate development and manufacturing of peptide-based drugs

Gyros Protein Technologies AB today announced the launch of three service offerings to support development and manufacturing of peptide-based drugs.

From Gyros Protein Technologies AB 22 Mar 2023

Fighting antibiotic-resistant "superbugs" with viruses

The Centers for Disease Control and Prevention warns that the increase in cases of the drug-resistant bacterial infection Shigella could be a predictor of what's to come for other bacteria.

21 Mar 2023

Co-infection with MRSA ‘superbug’ could make COVID-19 outcomes even more deadly

Global data shows nearly 10 per cent of severe COVID-19 cases involve a secondary bacterial co-infection – with Staphylococcus aureus, also known as Staph A., being the most common organism responsible for co-existing infections with SARS-CoV-2.

21 Mar 2023

Gut microbiota-derived biomarkers for identifying patients with fatty liver disease

A recent study at the University of Jyväskylä (Finland) compared the gut microbiota and gut-derived metabolites between healthy controls and individuals with fatty liver.

21 Mar 2023

Study highlights the role of intestinal T cells in modifying psychological stress responses

In experiments with mice and humans, a team led by Johns Hopkins Medicine researchers says it has identified a particular intestinal immune cell that impacts the gut microbiome, which in turn may affect brain functions linked to stress-induced disorders such as depression.

21 Mar 2023

Drugs News and Research

Researchers identify an enzyme associated with kidney fibrosis in both mice and humans

Common genetic signature may increase a person's risk of developing substance use disorders

Researchers discover how a single mechanosensitive protein induces fibrosis

Animal studies show potential of new drug to curb painful hyperinflammation from osteoarthritis

Researchers discover how a mutation in the desmosomal gene leads to arrhythmogenic cardiomyopathy

Study finds shared genetic risk variants across different substance use disorders

Naturally-occurring compound found in trees effective in fighting superbugs

Study reveals why COVID-19 subvariants spread rapidly among previously infected people

Public’s view of obesity has changed since the pandemic, survey shows

Disruption of the FcRn–IgG interaction may make AAV-based gene therapies effective

New study investigates effect of short-term PM2.5 exposure on blood lipids

End of covid emergency will usher in changes across the US health system

Gyros Protein Technologies introduces new PurePep EasyClean services to accelerate development and manufacturing of peptide-based drugs

Fighting antibiotic-resistant "superbugs" with viruses

Co-infection with MRSA ‘superbug’ could make COVID-19 outcomes even more deadly

Gut microbiota-derived biomarkers for identifying patients with fatty liver disease

Study highlights the role of intestinal T cells in modifying psychological stress responses

Snapping at new biotech breakthroughs with Gator Pro

Green tea holds potential as treatment for uterine fibroids, PCOS, and menopausal symptoms

Real-world studies show efficacy, safety of BLV monotherapy in patients with HDV-related compensated cirrhosis

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News